TIDE, currently taking place worldwide, was designed to provide rigorous evidence about the drug's safety, and the designers of the study had plans to enroll up to 15,000
more diabetes patients.
Not exact matches
Most meaningfully, I trained and supervised over 100 coaches who helped 100,000
patients lose
more than 1 million pounds to cut their risk of
diabetes in half.
Researchers from Aston Medical School in Birmingham looked at
more than 900,000
patients with high blood pressure, high cholesterol and type 2
diabetes and found marriage led to higher survival rates.
Patient Held Records
Diabetes UK supports any initiative that enables people with diabetes to be more involved with their o
Diabetes UK supports any initiative that enables people with
diabetes to be more involved with their o
diabetes to be
more involved with their own care.
Patients are eligible if they are enrolled in Medicaid and have two or
more chronic conditions such as substance use disorder, asthma,
diabetes or one single chronic condition of either HIV / AIDS, serious mental illness or serious emotional disturbance or complex trauma.
About 52 percent (34 of 66) of
patients had personality - related problems, although sometimes without a formal diagnosis and
more than a majority of
patients had at least one coexisting illness, including cancer, cardiac disease,
diabetes, stroke and others.
DPN is one of the earliest and most common pathological manifestations of
diabetes, occurring in
more than 75 percent of diabetic
patients.
Type 2
diabetes afflicts
more than 300 million people globally, and as many as 15 % of those
patients can not take the first - line therapy metformin because of kidney damage risks.
The results showed that, in
patients with established
diabetes, AET might be
more effective in reducing HbA1c (a measure of blood sugar control) and fasting glucose when compared with RT..
As
more and
more patients successfully manage
diabetes with drugs that increase their insulin sensitivity, doctors and researchers have observed a serious problem: The drugs seem to decrease the activity of cells that produce bone, leaving
patients prone to fractures and osteoporosis.
Medical scientists, on the other hand, are crunching billions of data points culled from millions of
patients about genetic mutations that make people
more vulnerable to diseases like
diabetes, heart disease and cancer.
Super obese
patients may have had
diabetes for a longer duration and are
more likely to have complications after surgery resulting in adverse health outcomes, explains Schauer.
As an endocrinologist, I specialize in the management of hormonal disorders, and this is business as usual for me:
More than 60 percent of my
patient visits focus on
diabetes.
New research shows that bariatric surgery (also known as obesity surgery) is much
more effective than an intensive lifestyle / medication intervention at reversing type 2
diabetes in
patients with only mild - to - moderate obesity.
More than half of this economic cost (56 %, $ 10.8 billion) was on accessing
diabetes treatment, including medication and hospital stays — and one half of these costs were out - of - pocket (paid for by the
patients), putting a huge financial burden on people with
diabetes.
We could even use
patients» own cells to develop a tailored approach to finding out how we can
more effectively treat them for diseases such as
diabetes.»
Compared to those who did not receive the drugs,
patients prescribed antidepressants were predominantly female, older, and
more likely to have hypertension,
diabetes, dyslipidaemia, obesity and comorbidities.
More than half of TKR
patients have a body mass index (BMI) within the obesity range (greater than 30 kg / m ²), which has been linked to a higher risk for related comorbidities such as
diabetes, hypertension, osteoarthritis; and in some studies, to higher medical costs and longer hospital stays.
The second question is
more difficult to answer than it might seem because the low prevalence of cancer and
diabetes in Laron
patients is counterbalanced by an abnormally high risk of death from other causes, especially accidents, alcohol, and convulsive disorders.
New findings from large - scale studies of
more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person's age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that
diabetes is a major risk factor for developing these diseases, even in
patients without heart disease.
«In addition, practitioners have to look for other risk factors that are
more common in obese
patients such as
diabetes, hypertension or coronary artery disease.»
To date,
diabetes treatment strategies are based on
patients either injecting insulin, taking medicine to make their body
more sensitive to insulin, or taking other drugs to stimulate insulin secretion.
If this condition persists for
more than two hours, a
patient will be diagnosed with
diabetes.
«
Diabetes complications make
patients more likely to fall down stairs.»
The results of a study involving
more than 9,000
patients, presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that Type 1
diabetes occurs significantly
more frequently in
patients with Juvenile Inflammatory Arthritis (JIA) than in the general population.
Despite increased understanding of heart disease risk factors and the need for preventive lifestyle changes,
patients suffering the most severe type of heart attack have become younger,
more obese and
more likely to have preventable risk factors such as smoking, high blood pressure,
diabetes and chronic obstructive pulmonary disease, according to a study scheduled for presentation at the American College of Cardiology's 65th Annual Scientific Session.
«Learning
more about the relationship between depression and circadian functioning might help us figure out strategies to improve physical and mental health for
patients with
diabetes.»
«As a result of these findings, we expect that
more physicians will consider gastric bypass surgery as a viable option for
patients with type 2
diabetes and mild to moderate obesity when previous attempts to lose weight and improve glycemic control have not been successful,» said Simonson.
«Moving forward, this
more sophisticated understanding of the relationship between
diabetes and obesity should enable researchers not only to develop therapies targeting these mechanisms, but also to identify the appropriate
patients to whom these therapies should be targeted.»
«While care must be taken in extrapolating preclinical findings to the care of particular
patients, we believe that these and other data do support a
more comprehensive and perhaps holistic approach to caring for
patients with
diabetes and / or obesity,» he adds.
In the largest study to date of the relationship between sleep apnea and
diabetes, a new study of
more than 8,500 Canadian
patients has demonstrated a link between obstructive sleep apnea (OSA) and the development of
diabetes, confirming earlier evidence of such a relationship from smaller studies with shorter follow - up periods.
According to Dr. Fonseca, who studies the efficacy of new
diabetes agents as the principal investigator of numerous clinical trials, «New medications offer
more options for us and our
patients.
This recommendation was based on the ability of screening to identify persons with
diabetes and evidence that
more - intensive blood pressure treatment was associated with reduced risk for cardiovascular events, including cardiovascular mortality, in
patients with
diabetes and hypertension.
The leading single cause of CKD is
diabetes which is increasing so it's expected that
more patients will be diagnosed with CKD in the future.
Kenya suggests that an important mechanism for improving this disconnect is to make
diabetes self - management education
more widely available to this
patient population.
In the paper «Having their say:
Patients» Perspectives and the Clinical Management of Diabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer more effective diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health o
Patients» Perspectives and the Clinical Management of
Diabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer more effective diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health o
Diabetes,» Dr. Leonard Jack, Jr., Ph.D., M.Sc., Director of the Division of Community Health at the National Center for Chronic Disease and Health Promotion, and his co-authors Dr. Leandris C. Liburd, Ph.D., M.P.H., M.A. and Dr. Pattie Tucker, Dr.P.H., M.P.H. and R.N., propose that healthcare providers can offer
more effective
diabetes support to their patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health o
diabetes support to their
patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health o
patients by understanding the cultural perspectives that explain their health behavior, to promote adherence and improve health outcomes.
However, Abraham's team found that IBD
patients diagnosed at an older age (e.g., 45 instead of 35), those with metabolic syndrome risk factors (
diabetes, hypertension, obesity, and high cholesterol), and most importantly, those with longer duration of disease regardless of age at diagnosis, are
more likely to develop NAFLD.
Screening
patients for
diabetes based solely on their age and weight — a recommendation from a leading medical expert group — could miss
more than half of high - risk
patients, according to a new Northwestern Medicine study...
Using data from a United Kingdom database known as The Health Improvement Network (THIN), researchers extracted health records of
more than 12,000
patients ages 55 and older who had Type 2
diabetes and heart failure but no prior history of heart attack, stroke, peripheral artery disease or atrial fibrillation.
Among
patients with hypertension who received the automated phone calls, those who also had cardiovascular disease, chronic kidney disease and
diabetes were up to 8.4 percent
more likely to achieve better blood pressure control than those who did not have these conditions.
Among 3,351 pairs of similar
patients — part of the overall study group — those
patients on statins were 250 percent
more likely than their non-statin-using counterparts to develop
diabetes with complications.
They were derived from skin cells obtained from
patients who have had type 1
diabetes for 50 years or
more and are members of the Joslin 50 - Year Medalist Program, and also from healthy controls.
In addition,
diabetes medications were also adjusted by diabetologists at the start and during the follow - up, and
patients were fed less carbohydrates and exercised
more - up to 300 minutes per week, he said.
A study published April 12 in the Journal of General Internal Medicine found that screening
patients for
diabetes based on only age and weight could be missing
more than half of high - risk
patients.
In addition, they point to the potential role for using these autoantibody tests for
more widespread screening to detect this newly discovered syndrome in other
patients with type 1
diabetes.
Virtually all
patients with type I
diabetes, the
more severe of the two types, must rely on daily injections of insulin to maintain their blood sugar levels.
The treatment did not work in three of the
patients, and it was also unlikely to work in
patients more than three months after diagnosis of
diabetes, said Dr Richard Burt of Northwestern.
To deliver a functional cure for all
patients with type 1
diabetes and an important new therapy for
patients with type 2 disease that require insulin to maintain control, ViaCyte is developing products with numerous advantages including a virtually unlimited supply of cells manufactured under quality - controlled conditions, and a potentially safer and
more optimal route of administration.
«The discovery of these genes means that we have to place
more emphasis on treating
diabetes in families rather than in individual
patients,» added Bell.
A large - scale metaanalysis on heart failure, using a huge individual
patient dataset, found that
diabetes was
more frequent in women than men, including
patients with both reduced and preserved ejection fraction (307).